rs17222723

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000392.5(ABCC2):​c.3563T>A​(p.Val1188Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0532 in 1,613,986 control chromosomes in the GnomAD database, including 2,596 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.054 ( 249 hom., cov: 32)
Exomes 𝑓: 0.053 ( 2347 hom. )

Consequence

ABCC2
NM_000392.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.72

Publications

101 publications found
Variant links:
Genes affected
ABCC2 (HGNC:53): (ATP binding cassette subfamily C member 2) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MRP subfamily which is involved in multi-drug resistance. This protein is expressed in the canalicular (apical) part of the hepatocyte and functions in biliary transport. Substrates include anticancer drugs such as vinblastine; therefore, this protein appears to contribute to drug resistance in mammalian cells. Several different mutations in this gene have been observed in patients with Dubin-Johnson syndrome (DJS), an autosomal recessive disorder characterized by conjugated hyperbilirubinemia. [provided by RefSeq, Jul 2008]
ABCC2 Gene-Disease associations (from GenCC):
  • Dubin-Johnson syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002881676).
BP6
Variant 10-99836239-T-A is Benign according to our data. Variant chr10-99836239-T-A is described in ClinVar as Benign. ClinVar VariationId is 298467.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.058 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCC2NM_000392.5 linkc.3563T>A p.Val1188Glu missense_variant Exon 25 of 32 ENST00000647814.1 NP_000383.2 Q92887
ABCC2XM_006717630.4 linkc.2867T>A p.Val956Glu missense_variant Exon 20 of 27 XP_006717693.1
ABCC2XM_047424598.1 linkc.3563T>A p.Val1188Glu missense_variant Exon 25 of 26 XP_047280554.1
ABCC2XR_945604.4 linkn.3768T>A non_coding_transcript_exon_variant Exon 25 of 30

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCC2ENST00000647814.1 linkc.3563T>A p.Val1188Glu missense_variant Exon 25 of 32 NM_000392.5 ENSP00000497274.1 Q92887
ENSG00000295976ENST00000734671.1 linkn.51-2060A>T intron_variant Intron 1 of 1
ENSG00000295976ENST00000734672.1 linkn.523-2060A>T intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.0539
AC:
8202
AN:
152062
Hom.:
245
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0594
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.0579
Gnomad ASJ
AF:
0.122
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0201
Gnomad FIN
AF:
0.0225
Gnomad MID
AF:
0.190
Gnomad NFE
AF:
0.0568
Gnomad OTH
AF:
0.0709
GnomAD2 exomes
AF:
0.0453
AC:
11386
AN:
251494
AF XY:
0.0457
show subpopulations
Gnomad AFR exome
AF:
0.0585
Gnomad AMR exome
AF:
0.0360
Gnomad ASJ exome
AF:
0.128
Gnomad EAS exome
AF:
0.000707
Gnomad FIN exome
AF:
0.0225
Gnomad NFE exome
AF:
0.0568
Gnomad OTH exome
AF:
0.0611
GnomAD4 exome
AF:
0.0531
AC:
77680
AN:
1461806
Hom.:
2347
Cov.:
32
AF XY:
0.0525
AC XY:
38200
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.0607
AC:
2032
AN:
33478
American (AMR)
AF:
0.0390
AC:
1746
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.131
AC:
3426
AN:
26136
East Asian (EAS)
AF:
0.000327
AC:
13
AN:
39700
South Asian (SAS)
AF:
0.0186
AC:
1603
AN:
86248
European-Finnish (FIN)
AF:
0.0232
AC:
1238
AN:
53416
Middle Eastern (MID)
AF:
0.129
AC:
744
AN:
5766
European-Non Finnish (NFE)
AF:
0.0569
AC:
63242
AN:
1111948
Other (OTH)
AF:
0.0602
AC:
3636
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
4536
9072
13607
18143
22679
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2372
4744
7116
9488
11860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0540
AC:
8223
AN:
152180
Hom.:
249
Cov.:
32
AF XY:
0.0523
AC XY:
3891
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.0599
AC:
2487
AN:
41508
American (AMR)
AF:
0.0579
AC:
885
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.122
AC:
423
AN:
3470
East Asian (EAS)
AF:
0.000772
AC:
4
AN:
5182
South Asian (SAS)
AF:
0.0205
AC:
99
AN:
4818
European-Finnish (FIN)
AF:
0.0225
AC:
238
AN:
10600
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.0567
AC:
3858
AN:
67996
Other (OTH)
AF:
0.0707
AC:
149
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
387
774
1160
1547
1934
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0604
Hom.:
260
Bravo
AF:
0.0586
TwinsUK
AF:
0.0607
AC:
225
ALSPAC
AF:
0.0555
AC:
214
ESP6500AA
AF:
0.0595
AC:
262
ESP6500EA
AF:
0.0617
AC:
531
ExAC
AF:
0.0430
AC:
5221
Asia WGS
AF:
0.0190
AC:
68
AN:
3478
EpiCase
AF:
0.0661
EpiControl
AF:
0.0727

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25087612, 18926681, 16628674) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ABCC2-related disorder Benign:1
Mar 06, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Dubin-Johnson syndrome Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
0.0030
DANN
Benign
0.17
DEOGEN2
Benign
0.088
T;T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.087
N
LIST_S2
Benign
0.19
.;T
MetaRNN
Benign
0.0029
T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
-0.52
N;N
PhyloP100
-2.7
PrimateAI
Benign
0.26
T
PROVEAN
Benign
0.71
.;N
REVEL
Benign
0.21
Sift
Benign
0.97
.;T
Sift4G
Benign
1.0
.;T
Polyphen
0.0
B;B
Vest4
0.097
MPC
0.051
ClinPred
0.0029
T
GERP RS
-11
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.089
gMVP
0.28
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17222723; hg19: chr10-101595996; COSMIC: COSV64985796; API